If you’ve started to notice the early signs of hair loss, it’s easy to wonder what’s causing you to shed hair.Telogen ...

The approval stipulates use of deuruxolitinib in adults with severe alopecia areata. The JAK1/2 inhibitor is the third oral ...

A local hair salon aims to help women with hair loss regain their confidence. Her Glory owner Tiffany Combs opened her uptown ...

Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window The efficacy of low-dose oral minoxidil for the treatment of alopecia may not be affected by the concomitant use of ...

An expert consensus by Spanish dermatologists offers treatment recommendations for androgenetic alopecia, the most common cause of hair loss, using a combination of medications and hair ...

Welcome to It’s Textured, a monthly column where we untangle the joy, trauma, confusion, and frustration that can come with ...

A literature review found a link between COVID-19 vaccination and alopecia, with most cases experiencing hair loss within 1 month after the first dose. However, the small sample size and limited ...

Investigators conducted a case-control study to investigate the corneal topography parameters and biomechanics in patients ...

Deuruxolitinib is the third treatment and third JAK inhibitor approved by the FDA for severe alopecia areata. Baricitinib ...

The FDA approval is based on data gathered from two Phase III studies where over 30% of the patients gained 80% or more ...

It delivers specialized cells directly to balding spots in patients with alopecia areata The patch is not yet available and may also have applications for treatment of other autoimmune disorders ...